Literature DB >> 18589285

[Dyspnea in lung cancer].

A Bonnichon1, H Le Floch, F Rivière, E Staub, A Mairovitz, C Marotel, F Vaylet, J Margery.   

Abstract

Dyspnea is a subjective symptom defined as an experience of uncomfortable and difficult breathing which strongly affects the quality of life. It is the most common symptom in lung cancer but its physiopathology remains unclear. Dyspnea is due to cancer itself, specific therapies or comorbidities. To evaluate intensity of dyspnea, analogue visual and verbal rating scales need to be preferred. Diagnosis of underlying cause, based on rational and non invasive strategy is needed to perform effective treatment if possible. Despite its frequency, few therapies are really effective, except nonpharmacologic measures: only morphine can be actually recommend, especially with naive patients. In palliative cases, if dyspnea is uncontrolled, benzodiazepine can be used and may represent ethic approach.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18589285     DOI: 10.1016/j.pneumo.2008.03.003

Source DB:  PubMed          Journal:  Rev Pneumol Clin        ISSN: 0761-8417


  1 in total

1.  Morphine versus methylprednisolone or aminophylline for relieving dyspnea in patients with advanced cancer in China: a retrospective study.

Authors:  Cong Tian; Jiong-Yi Wang; Mei-Ling Wang; Bin Jiang; Lu-Lu Zhang; Feng Liu
Journal:  Springerplus       Date:  2016-11-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.